|Articles|July 21, 2003
Special Report: MULTIPLE MYELOMA MENACE
Besides Velcade which was just approved to treat multiple myeloma, many other drugs are waiting in the wings.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
General Awareness of PBM Practices Driving Optimism for Independent Pharmacies | NCPA 2025
2
COVID-19 Vaccination Benefits Patients With Systemic Lupus Erythematosus
3
FDA Releases Biosimilar Guidance Pushing to Streamline Development
4
How PBMs Legally Challenged Arkansas’ Pharmacy Ownership Law | NCPA 2025
5




















































































































































